Highlights
NASDAQ: SPRO       Spero Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
13.27   -0.17 (1.26%)  13.248 - 13.49  10,945

Overview

 
Avg Volume (4 weeks):247,510
4 Weeks Range:11.27 - 14.60
4 Weeks Price Volatility (%):
60.06%
52 Weeks Range:5.25 - 14.60
52 Weeks Price Volatility (%):
85.78%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Spero Therapeutics Inc is a US-based clinical-stage biopharmaceutical company. It focuses on identifying, developing and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections. The company's product candidate, SPR994, is designed as a broad-spectrum oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It has developed platform technology known as Potentiator Platform to develop drugs to expand the spectrum and potency of existing antibiotics, including formerly inactive antibiotics, against Gram-negative bacteria. In addition, the company is developing SPR720, an oral antibiotic designed for the treatment of pulmonary non-tuberculous mycobacterial infections. The pipeline products include SPR741, SPR206, and SPR720.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2740  2931  583  3142 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 LK 1.38+1.38 
 OAS 0.155-0.014 
 HTZ 1.780.00 
 BLRX 2.315+0.835 
 AMTD 39.97-0.85 
 PGNX 4.10-0.425 
 XOG 0.271-0.062 
 AAPL 109.18-6.14 
 NIO 30.08-1.91 
 TMUSR 0.121+0.031